Perioperative management and monitoring of a super-obese patient

Obesity Surgery

Volumn 14, Issue 10, 2004, Pages 1423-1427

  Pellis, Tommaso ^a   Leykin, Yigal ^a   Albano, Giovanni ^a   Zannier, Gianfederico ^a   Di Capua, Gabriella ^b   Marzano, Bernardo ^a   Gullo, Antonino ^b  

^a S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Acceleromyography; Anesthesia; BIS; Desflurane; HemoSonic; Intraoperative monitoring; Perioperative management; Remifentanil; Rocuronium; Super morbid obesity

Indexed keywords

DESFLURANE; KETOROLAC; PROPOFOL; REMIFENTANIL; ROCURONIUM; TRAMADOL;

ADULT; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTERIAL PRESSURE; ARTICLE; CASE REPORT; DEVICE; DOSE CALCULATION; ENDOTRACHEAL INTUBATION; HEMODYNAMIC MONITORING; HUMAN; INHALATION ANESTHESIA; LAPAROSCOPIC SURGERY; MALE; MORBID OBESITY; OXYGEN THERAPY; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE PAIN; PRIORITY JOURNAL; STOMACH BYPASS;

ADULT; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, GENERAL; BODY MASS INDEX; FOLLOW-UP STUDIES; GASTRIC BYPASS; GASTROSCOPY; HUMANS; ITALY; LAPAROSCOPY; MALE; MONITORING, PHYSIOLOGIC; OBESITY, MORBID; PERIOPERATIVE CARE; POSTOPERATIVE CARE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 10644277995     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892042583914     Document Type: Article

References (20)

1. Steinbrook R. Surgery for Severe Obesity. N Engl J Med 2004; 350: 1075-9.
2. Ogunnaike BO, Jones SB, Jones DB et al. Anesthetic considerations for bariatric surgery. Anesth Analg 2002; 95: 1793-805.
3. Servin F, Pommereau R, Leresche M. Use of propofol to induce and maintain general anaesthesia in morbidly obese patients. Eur J Anaesth 1991; 8: 323-4.
4. Adams JP, Murphy PG. Obesity in anaesthesia and intensive care. Br J Anaesth 2000; 85: 91-108.
5. Rose DK, Cohen MM, Wigglesworth DF et al. Critical respiratory events in the postanesthesia care unit. Patient, surgical, and anesthetic factors. Anesthesiology 1994; 81: 410-18.
6. Song D, Joshi GP, White PF. Titration of volatile anesthetics using bispectral index facilitates recovery after ambulatory anesthesia. Anesthesiology 1997; 87: 842-8.
7. Domino KB, Posner KL, Caplan RA. Awareness during anesthesia. Anesthesiology 1999; 90: 1053-61.
8. De Baerdemaeker LEC, Struys MMRF, Jacobs S et al. Optimization of desflurane administration in morbidly obese patients: a comparison with sevoflurane using an 'inhalation bolus' technique. Br J Anaesth 2003; 91: 638-50.
9. Juvin P, Vadam C, Malek L et al. Postoperative recovery after desflurane, propofol, or isoflurane anaesthesia among morbidly obese patients: a prospective, randomized study. Anesth Analg 2000; 91: 714-9.
10. Myles PS, Leslie K, McNeil J et al. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet. 2004; 363: 1757-63.
11. Struys MM, De Smet T, Versichelen LF et al. Comparison of closed-loop controlled administration of propofol using Bisprectal Index as the controlled variable versus 'standard practice' controlled administration. Anesthesiology 2001; 95: 6-17.
12. Hoke JF, Shlugman D, Dershwitz M et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology 1997; 87: 533-41.
13. Dershwitz M, Hoke JF, Rosow CE et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996; 84: 812-20.
14. Egan TD, Huizinga B, Gupta SK et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998; 89: 562-73.
15. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics and rational opioid selection. Anesthesiology 1991; 74: 53-63.
16. Huges MA, Glass PSA, Jacobs JR: Context-sensitive half-times in multicompartiment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1991; 76: 334-41.
17. Puhringer FK, Keller C, Kleinsasser A et al. Pharmacokinetics of rocuronium bromide in obese female patients. Eur J Anaesthesiol 1999; 16: 507-10.
18. Wierda JMKH, Kleef UW, Lambalk LM et al. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth 1991; 38: 430-5.
19. Leykin Y, Pellis T, Lucca M et al. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg 2004; 99: 1086-9.
20. Gaszynski T, Gaszynski W, Strzelczyk J. General anaesthesia with remifentanil and cisatracurium for a superobese patient. Eur J Anaesthesiol 2002; 20: 77-8.